P1‐13: Effect of bromhexine among COVID‐19 patients ‐ A meta‐analysis
Sign Up to like & getrecommendations! Published in 2021 at "Respirology"
DOI: 10.1111/resp.14150_13
Abstract: Background and Aims: Bromhexine is an affordable and easily available mucolytic that appears to be beneficial among patients with COVID-19. It acts as a potent inhibitor of transmembrane serine protease 2, which is essential for… read more here.
Keywords: bromhexine among; covid patients; bromhexine; among covid ... See more keywords